Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis
Authors
Keywords
-
Journal
JOURNAL OF PHARMACY AND PHARMACOLOGY
Volume 69, Issue 12, Pages 1672-1683
Publisher
Wiley
Online
2017-08-17
DOI
10.1111/jphp.12802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Antifungal Agents
- (2016) Jeniel E. Nett et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Comparison between liposomal formulations of amphotericin B
- (2016) Jill P Adler-Moore et al. MEDICAL MYCOLOGY
- The fungicidal activity of amphotericin B requires autophagy-dependent targeting to the vacuole under a nutrient-starved condition in Saccharomyces cerevisiae
- (2016) Michiru Yoshioka et al. MICROBIOLOGY-SGM
- Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis
- (2016) Laiza M. Steimbach et al. MYCOSES
- Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry
- (2016) Roberta Della Pepa et al. SUPPORTIVE CARE IN CANCER
- Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa
- (2016) Susan Meiring et al. PLoS Neglected Tropical Diseases
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Incidence, Predictors, and Impact on Hospital Mortality of Amphotericin B Nephrotoxicity Defined Using Newer Acute Kidney Injury Diagnostic Criteria
- (2015) Paulo Novis Rocha et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
- (2015) Tihana Bicanic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
- (2015) Eric J Bow et al. BMC INFECTIOUS DISEASES
- Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study
- (2015) Diego R. Falci et al. MYCOSES
- Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
- (2014) Daniela Tacke et al. ANNALS OF HEMATOLOGY
- Deoxycholate Amphotericin B and Nephrotoxicity in the Pediatric Setting
- (2014) David F. Bes et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Budget Impact Analysis of Liposomal Amphotericin B and Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections in the United States
- (2014) Hongbo Yang et al. Applied Health Economics and Health Policy
- Nephrotoxicity of Different Formulations of Amphotericin B: Summarizing Evidence by Network Meta-analysis
- (2013) Andrea Messori et al. CLINICAL INFECTIOUS DISEASES
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis
- (2012) S. Mistro et al. CLINICAL INFECTIOUS DISEASES
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
- (2012) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- (2012) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS
- (2012) O. Lortholary et al. CLINICAL MICROBIOLOGY AND INFECTION
- ADDIS: A decision support system for evidence-based medicine
- (2012) Gert van Valkenhoef et al. DECISION SUPPORT SYSTEMS
- A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (FungisomeTM) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India
- (2012) MP Jadhav et al. INDIAN JOURNAL OF CANCER
- Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
- (2012) J. P. T. Higgins et al. Research Synthesis Methods
- Amphotericin B Lipid Complex in the Management of Invasive Fungal Infections in Immunocompromised Patients
- (2011) Matteo Bassetti et al. CLINICAL DRUG INVESTIGATION
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
- (2011) Alison G. Freifeld et al. CLINICAL INFECTIOUS DISEASES
- Multicriteria benefit–risk assessment using network meta-analysis
- (2011) Gert van Valkenhoef et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis
- (2011) Tommi Tervonen et al. STATISTICS IN MEDICINE
- Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2
- (2011) David C. Hoaglin et al. VALUE IN HEALTH
- Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
- (2011) Jeroen P. Jansen et al. VALUE IN HEALTH
- Injectable Lipid Emulsions—Advancements, Opportunities and Challenges
- (2010) Ketan Hippalgaonkar et al. AAPS PHARMSCITECH
- Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS‐Associated Acute Cryptococcal Meningitis: A Randomized, Double‐Blind Clinical Trial of Efficacy and Safety
- (2010) Richard J. Hamill et al. CLINICAL INFECTIOUS DISEASES
- Updated guidelines for managing fungal diseases in hematology patients
- (2010) Yosr Hicheri et al. Expert Review of Anti-Infective Therapy
- Checking consistency in mixed treatment comparison meta-analysis
- (2010) S. Dias et al. STATISTICS IN MEDICINE
- Liposomal Amphotericin B
- (2009) Marit D. Moen et al. DRUGS
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Bayesian Meta-Analysis of Multiple Treatment Comparisons: An Introduction to Mixed Treatment Comparisons
- (2008) Jeroen P. Jansen et al. VALUE IN HEALTH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started